OTLC

Oncotelic Therapeutics (QB) (OTLC)

Oncotelic Therapeutics Inc (QB)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:OTLC

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/02/03	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2023/10/30	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2023/08/23	23 : 30	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2023/08/19	06 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2023/07/13	22 : 25	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2023/07/13	22 : 15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2023/06/30	22 : 26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2023/06/30	22 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2023/06/21	01 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2023/06/17	01 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2023/05/31	22 : 39	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2023/05/20	05 : 45	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2023/05/03	06 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2023/04/20	19 : 04	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2023/04/15	06 : 02	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2023/04/03	19 : 04	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2023/03/02	23 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2022/12/07	22 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2022/11/25	23 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2022/11/19	07 : 02	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2022/11/15	04 : 25	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2022/09/28	22 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2022/08/29	22 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2022/08/22	21 : 32	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2022/08/16	03 : 34	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2022/07/15	20 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2022/06/22	21 : 47	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2022/05/23	19 : 22	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2022/05/12	06 : 11	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)
2022/04/16	05 : 28	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:OTLC	Oncotelic Therapeutics Inc (QB)